Shortening the antibiotic course for the treatment of neonatal coagulase-negative staphylococcal sepsis: Fine with three days?

Neonatology

Volumn 101, Issue 2, 2012, Pages 101-105

  Hemels, Marieke A C ^a   Van Den Hoogen, Agnes ^a   Verboon Maciolek, Malgorzata A ^a   Fleer, André ^a,b   Krediet, Tannette G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibiotic treatment; Coagulase negative staphylococci; Neonatal sepsis

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; GENTAMICIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CENTRAL VENOUS CATHETER; COAGULASE NEGATIVE STAPHYLOCOCCAL SEPSIS; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN CARE; PRIORITY JOURNAL; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; THROMBOCYTE; TREATMENT DURATION; TREATMENT RESPONSE;

ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; CATHETERIZATION, CENTRAL VENOUS; COAGULASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TREATMENT OUTCOME;

STAPHYLOCOCCUS;

EID: 84856827100     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000330600     Document Type: Article

References (19)

1. Stoll BJ, Hansen N: Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol 2003; 27: 293-301. (Pubitemid 37099810)
2. Isaacs D, Australasian Study Group For Neonatal Infections: A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal Neonatal Ed 2003; 88:F89-F93. (Pubitemid 36269526)
3. Van den Hoogen A, Gerards LJ, Verboon-Maciolek MA, Fleer A, Krediet TG: Longterm trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology 2010; 97: 22-28.
4. Palazzi DL, Klein JO, Baker CJ: Bacterial sepsis and meningitis; in Remington JS, Klein JO, (eds): Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, Elsevier and Saunders, 2006, pp 247-295.
5. Flynn PM: Diagnosis and management of central venous catheter-related bloodstream infections in pediatric patients. Pediatr Infect Dis J 2009; 28: 1016-1017.
6. Metjian TA, Prasad PA, Kogon A, Coffin SE, Zaoutis T: Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J 2008; 27: 106-111.
7. Di Pentima MC, Chan S: Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital. Pediatr Infect Dis J 2010; 29: 707-711.
8. Franz AR, Steinbach G, Kron M, Pohlandt F: Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104: 447-453. (Pubitemid 29424663)
9. Franz AR, Bauer K, Schalk A, Garland SM, Bowman ED, Rex K, Nyholm C, Norman M, Bougatef A, Kron M, Mihatsch WA, Pohlandt F, International IL-8 Study Group: Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial. Pediatrics 2004; 114: 1-8. (Pubitemid 38857558)
10. Hemels MA, Verboon-Maciolek MA, Gerards LJ, Krediet TG, Fleer A: Rapid clearance from the bloodstream of coagulasenegative staphylococci in infants with lateonset sepsis. Pediatr Infect Dis J 2009; 28: 853-854.
11. Krediet TG, Jones ME, Gerards LJ, Fleer A: Clinical outcome of cephalotin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates. Relation to methicillin resistance and mec A gene carriage of blood isolates. Pediatrics 1999; 103:E29.
12. Verboon-Maciolek MA, Thijsen SF, Hemels MA, Menses M, van Loon AM, Krediet TG, Gerards LJ, Fleer A, Voorbij HA, Rijkers GT: Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res 2006; 59: 457-461. (Pubitemid 43740088)
13. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK: Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics 2002; 110: 285-291. (Pubitemid 34833012)
14. Hemels MAC, van den Hoogen A, Verboon-Maciolek MA, Fleer A, Krediet TG: A sevenyear survey of management of coagulasenegative staphylococcal sepsis in the neonatal intensive care unit: vancomycin may not be necessary as empiric therapy. Neonatology 2011; 100: 180-185.
15. Ehl S, Gering B, Bartmann P, Högel J, Pohlandt F: C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997; 99: 216-221. (Pubitemid 27148873)
16. Pickering LK, Peter G, Baker CJ: Red Book: Report of the Committee on Infectious Diseases, ed 28, revised. Elk Grove Village, American Academy of Pediatrics, 2009, p 613.
17. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, OGrady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK: Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
18. Zingg W, Pfister R, Posfay-Barbe KM, Huttner B, Touveneau S, Pittet D: Secular trends in antibiotic use among neonates: 2001-2008. Pediatr Infect Dis J 2011; 30: 365-370.
19. Patel SJ, Saiman L: Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. Clin Perinatol 2010; 37: 547-563.